Other Private Equity/Strategic Investments
Cancer drugs maker Immuneel Therapeutics raises Rs.100-Cr from UAE pharma co.
Bengaluru-based biotech startup Immuneel Therapeutics has raised INR 100 crore from Taiba Middle East FZ LLC in an extended Series A round.The firm has been valued at around INR 587 crore (USD 71 million) post-allotment. Following the fresh proceeds, Taiba Middle East FZ holds a 17% stake in Immuneel Therapeutics.Founded by Kiran Mazumdar Shaw, Siddhartha Mukherjee and Kush Parwar, Immuneel Therapeutics is engaged in developing cell and gene therapies for cancer patients.
Between Jan 2022 and Apr 2022, Immuneel Therapeutics had raised over USD 27 M from Khosla Ventures, TrueNorth, Eight Roads Ventures and Others
Want to receive such news items in your inbox? Click Here to sign up for a trial.
